Stock Market LIVE Updates: Shilpa Medicare today informed that its Unit 7, at Nacharam, Hyderabad, Telangana, has received the GMP Certification from EMA, Europe.
The company, in an exchange filing, said, "This is to inform you that the Shilpa Medicare Limited, Unit 7, Nacharam, Hyderabad, Telangana, India had completed an
inspection from EMA, Europe from 24th to 26th September 2024. The Company has received the GMP Certification after successful closure of the inspection".
The company added that Shilpa Medicare, Unit VII, has an Analytical Services Division (QC) and a Bio Analytical Department. Both laboratories are approved by
USFDA. The Bio-Analytical Laboratory is already approved by EMA, Europe, it said.
This laboratory is involved in testing drug substances, raw materials, packing materials and finished products. It is also engaged in other analytical activities like analytical method validations, method transfers and other miscellaneous analytical studies.
The laboratory has been testing samples for final release into US, EU and other markets, the company said.